Mumbai: Lowe Lintas has been appointed as the brand and communications partner for Cofsils, a prominent player in the throat relief category under the Cipla Health portfolio. The win follows a multi-agency pitch involving several top creative agencies and marks a significant addition to Lowe Lintas’ growing footprint in the health and wellness space.
Cofsils offers a broad range of products including throat lozenges, cough drops, and cough syrups. With this mandate, Lowe Lintas will lead the integrated brand communications across the Cofsils portfolio. The scope includes brand strategy, creative development, digital-first storytelling, and healthcare professional (HCP) communication, all aimed at making Cofsils the first choice at the first sign of discomfort.
Commenting on the association, Shivam Puri, Managing Director and CEO, Cipla Health, said, “From strategic insights to creative storytelling, Lowe Lintas consistently impressed us with their depth of thinking and consumer empathy. We’re confident they are the right partner to help Cofsils unlock new growth pathways.”
The win further strengthens Lowe Lintas’ longstanding relationship with Cipla Health, reinforcing its reputation as a preferred agency partner for healthcare brands aiming to grow and lead through impactful storytelling and innovation.
Subramanyeswar S, Group CEO – India & CSO – APAC, MullenLowe Global, added, “Earning repeat trust is the highest compliment. We are proud to deepen our partnership with Cipla Health. Together, we look forward to shaping a healthier future for people.”
Sharing her perspective on the mandate, Anaheeta Goenka, COO – Lowe Lintas, said, “We’re thrilled to partner with Cofsils on this exciting mandate. Winning this pitch was no small feat – the task at hand is both challenging and inspiring. Reigniting desire for a challenger brand and shifting consumer preference in a cluttered market will demand the best of our strategic and creative strengths.”
